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Abstract
The African trypanosome, Trypanosoma brucei, maintains an integral link between cell cycle regulation and differentiation
during its intricate life cycle. Whilst extensive changes in phosphorylation have been documented between the mammalian
bloodstream form and the insect procyclic form, relatively little is known about the parasite’s protein kinases (PKs) involved
in the control of cellular proliferation and differentiation. To address this, a T. brucei kinome-wide RNAi cell line library was
generated, allowing independent inducible knockdown of each of the parasite’s 190 predicted protein kinases. Screening of
this library using a cell viability assay identified $42 PKs that are required for normal bloodstream form proliferation in
culture. A secondary screen identified 24 PKs whose RNAi-mediated depletion resulted in a variety of cell cycle defects
including in G1/S, kinetoplast replication/segregation, mitosis and cytokinesis, 15 of which are novel cell cycle regulators. A
further screen identified for the first time two PKs, named repressor of differentiation kinase (RDK1 and RDK2), depletion of
which promoted bloodstream to procyclic form differentiation. RDK1 is a membrane-associated STE11-like PK, whilst RDK2
is a NEK PK that is essential for parasite proliferation. RDK1 acts in conjunction with the PTP1/PIP39 phosphatase cascade to
block uncontrolled bloodstream to procyclic form differentiation, whilst RDK2 is a PK whose depletion efficiently induces
differentiation in the absence of known triggers. Thus, the RNAi kinome library provides a valuable asset for functional
analysis of cell signalling pathways in African trypanosomes as well as drug target identification and validation.
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Introduction
The protozoan parasite, Trypanosoma brucei, is spread by the
tsetse fly and causes both Human and Animal African Trypano-
somasis in sub-Saharan Africa. It has a complex life cycle, whereby
the parasite differentiates multiple times through a series of
morphologically and biochemically distinct life cycle stages in each
host. Some life cycle stages, such as the short stumpy bloodstream
form (BSF) and the metacyclic form in the tsetse salivary glands
are cell cycle arrested and pre-adapted for life in the new host,
while others, such as the long slender BSF and the insect procyclic
form (PCF) and epimastigote form proliferate. The signal
transduction pathways regulating differentiation events are just
starting to be unravelled. For example, differentiation of the long
slender BSF to the short stumpy BSF occurs via a quorum-sensing
pathway in response to an as yet unknown parasite-derived
molecule termed Stumpy Induction Factor (SIF) [1–3]. A number
of protein kinases (PKs), ZFK [4], MAPK5 [5] and TOR4 [6],
have all been identified as negative regulators of this differentiation
event, but the links between these kinases are not clear at present.
Stumpy cells, which specifically express the citrate transporter
PAD1 required to transduce a citrate and/or cis-aconitate signal
[2], then differentiate to the PCF in the tsetse fly midgut, and a
protein phosphatase cascade regulating stumpy to PCF differen-
tiation has been described [7,8], although the antagonising PKs
are not yet known. A MAP Kinase Kinase, MKK1, has also
recently been shown to regulate later differentiation steps in the
tsetse fly, since MKK1 null mutants are unable to establish salivary
gland infections [9].
The cell division cycles of proliferative T. brucei stages are also
complex, in part because of the need to faithfully replicate and
segregate the parasite’s several single copy organelles, and in part
because there are key regulatory differences between T. brucei and
mammalian cell cycles, as well as between different life cycle stages
of the parasite. BSF T. brucei appear to have unusual mechanisms
for regulating cell cycle checkpoints, as a block in mitosis inhibits
cytokinesis but not successive rounds of nuclear DNA synthesis or
kinetoplast replication and segregation [10]. A number of PKs
have now been shown to regulate cell cycle progression in BSF T.
brucei, for example, CRK1 and CRK3, which regulate G1/S and
G2/M, respectively [11], AUK1 and TLK1, which are required
for progression through mitosis [12–14], and PLK, PK50 and
PLOS Pathogens | www.plospathogens.org 1 January 2014 | Volume 10 | Issue 1 | e1003886
PK53 which regulate cytokinesis [15,16], but many cell cycle/
checkpoint regulators undoubtedly remain to be identified.
T. brucei has 158 eukaryotic PKs (ePKs), 12 predicted
pseudokinases and 20 atypical PKs (aPKs), which phosphorylate
proteins despite their lack of a conserved PK structure [17–19].
Although T. brucei does not possess any canonical receptor tyrosine
kinase or tyrosine kinase-like kinase homologues, members of the
other four major groups of ePKS, the AGC, CAMK, CMGC and
STE kinases, are present, as are a number of ‘Other’ PKs. The
CMGC, STE and Other/NEK groups of PKs are relatively
expanded in T. brucei compared to humans. In the original analysis
of the T. brucei kinome, additionally over 30 ‘Orphan’ PKs, which
do not display sequence homology to any previously described PK
families, were identified [17], although several of these have since
been allocated to ePK groups [18,19]. To date, 64 ePKs, 9
pseudokinases and 9 aPKs have been reported in at least one study
to be essential for BSF proliferation, although some discrepancies do
exist between different data sets, presumably reflecting the different
methods employed to test essentiality. Some of these essential
kinases have been identified via RNAi studies of individual genes
[6,11,12,12,15,20], while others were identified via an RNAi screen
of 30 PKs [21], an RNAi screen of CDXG kinases [22], a
conditional null mutant screen of 20 targets [23] and a global RNAi
target sequencing (RIT-seq) screen [24]. Here, we report the
generation and screening of a global T. brucei kinome RNAi library
of individual cell lines to identify essential PKs, cell cycle regulators
and negative regulators of BSF to PCF differentiation.
Results and Discussion
Generation of the kinome RNAi library
In order to facilitate the high throughput generation of a library
of individually targeted RNAi plasmids, the tetracycline-inducible,
stem-loop RNAi vector, pRPaISL [25], was modified for
recombineering. pRPaISL was selected because it integrates at a
single, tagged locus resulting in high reproducibility between
independent clones, and the modified vector, pGL2084 (Figure
S1), allowed the generation of a stem-loop RNAi construct for a
given gene in a single recombinase reaction. In total, RNAi
constructs were created to target all 190 PK genes (Table S1).
While the majority of RNAi constructs targeted a single PK, due
to high levels of nucleotide sequence identity shared by some
arrayed or paralogous PK genes, 6 plasmids each targeted two or
more PKs. Each plasmid was linearised by digestion with AscI and
transfected individually into monomorphic T. brucei 2T1 BSF
parasites [25]; at least two independent clones were recovered for
further analysis.
Screening the kinome RNAi library for protein kinases
essential for proliferation in vitro
To allow identification of essential kinases, a 72 hr cell viability
assay using Alamar Blue was performed for two independent
clonal cell lines for each gene. 48 cell lines (53 genes) showed loss
of fitness (LOF) phenotypes (.10% reduction in Alamar Blue
value in comparison with uninduced control values) after RNAi
induction in at least one of the two biological replicates (Table S1).
A secondary screen was performed on the LOF RNAi cell lines,
examining their proliferation in culture over 96 hr following RNAi
induction. At this stage, new cell lines were generated to
knockdown CLK1 and CLK2, and NEK12.1 and NEK12.2
independently to facilitate subsequent characterisation of these
kinases. In total, 42 cell lines (46 genes, including CLK1 and
NEK12.2 as well as the STE11 kinase Tb927.11.14070 and
TOR2, which had not exhibited a LOF phenotype by Alamar
Blue assay when depleted (see below)) showed a growth defect
(either slow growth (16 cell lines), growth arrest (15 cell lines) or
cell death (11 cell lines)) under these conditions (Table 1, Figures 1,
2 and S2). Nine cell lines examined in the secondary screen did not
display any significant growth defects upon RNAi induction
(Figure S2A), including LDK1, depletion of which has previously
been reported to result in only a minor growth defect in BSF T.
brucei [26], and thus were not studied further here.
Amongst the 45 genes whose depletion results in a LOF
phenotype were members of all the PK families represented in T.
brucei (see Table 1 for gene IDs). Fifteen of these PKs had been
studied previously and reported either to be essential for BSF T.
brucei proliferation in vitro, or to be required for optimal growth.
These were the AGC family kinases, PK50 and PK53 [16], the
CMGC family cdc2-related kinases, CRK1, CRK3 and CRK12
[11,27], the cdc2-like kinase CLK1 [22], the PKA catalytic
subunits, PKAC1 and PKAC2 [28], GSK3-short [29], the Aurora
kinase, AUK1 [12,13], the tousled-like kinase, TLK1 [14], CK1.2
[30] and the TOR kinases, TOR1, TOR2 and TOR4 [6,20].
Twenty other PKs reported in a previous global RITseq RNAi
screen [24] to be essential for BSF growth were also detected here
(Table S1). These include CRK9, MPK2, and CK2A1. In
addition, depletion of TbAUK3, in contrast to an earlier study
[12], or down-regulation of the tousled-like kinase, TLK2,
generated substantial growth defects. A ULK homologue
(Tb927.11.8150), a potential regulator of autophagy [31], was
also observed to result in a moderate growth defect upon RNAi
ablation in this study. Other RITseq ‘hits’ confirmed by this study
include the AGC kinase, Tb927.3.2440, the CMGC/RCK kinase,
Tb927.3.690, the CAMKs Tb927.7.2750 and Tb927.8.870, the
CAMKK, Tb927.10.15300, the orphan kinase, PK6, NEK12.2
and two members of the pseudokinase family (Tb927.9.6560 and
Tb927.7.3210).
Fourteen PKs were shown here to be important for the
proliferation of BSF T. brucei in culture for the first time. These
include the AGC kinase Tb927.9.4910, which contains a PK
domain most similar to PDK1, a master AGC kinase in other
eukaryotes [32] the CAMK Tb927.7.6220, a number of CMGC
Author Summary
The African trypanosome, which is transmitted by the
tsetse fly, causes the usually fatal disease Sleeping Sickness
in humans and a wasting disease, called Nagana, in
livestock in sub-Saharan Africa. There are no vaccines
available against the diseases, and various problems are
associated with current drug treatments (including toxicity
to the patient and parasite drug resistance). Thus, it is
important to identify essential parasite proteins that could
be targeted by novel drugs. Protein kinases (PKs) are
important cell signalling molecules, and are generally
considered to have potential as drug targets. Here we
report the construction of a library of trypanosome cell
lines that allows us to specifically deplete each of the
trypanosome’s 190 PKs individually and analyse their
function. Using this library, we show that $42 PKs are
essential for proliferation of the mammalian-infective
bloodstream form of the parasite (and thus have potential
as drug targets), and demonstrate that 24 of these play
important roles in coordinating cell division. We also shed
light on how the parasite develops during its life cycle as it
passes from the mammalian bloodstream form to the
tsetse fly gut by identifying the first two PKs that regulate
this life cycle developmental step.
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kinases: CRK2, CRK6, the MAPK, KFR1, and a serine-arginine-
rich protein kinase (Tb927.6.4970), as well as an undefined
CMGC PK (Tb927.11.5340) and WEE1. Several STE family
members, which are potential upstream activators of the MAPKs,
were also newly identified as playing important or essential roles in
cell growth, including two STE11-type PKs (Tb927.11.2040 and
Tb927.8.1100), the STE20 family MAPKKK, SLK1, and an
unclassified STE kinase, Tb927.10.2040. Three atypical protein
kinases, ATR and RIO1, were also shown for the first time to be
important for cell growth.
Overall, the loss of fitness phenotypes detected in our kinome-
wide RNAi screen has an excellent correlation with previous
studies knocking down individual genes (Tables 1 and S1).
Additionally, two protein kinases shown previously to be non-
essential for growth by gene knockout, ZFK [4] and MKK1 [33],
did not show a loss of fitness phenotype in our screen. However,
one notable discrepancy with the published literature was PLK,
which has been shown to be essential in BSF [15], but gave no
RNAi phenotype in this study. qPCR analysis, however, revealed
that in the two cell lines used in this study, no reduction in PLK
mRNA was detected after RNAi induction, explaining the lack of
the expected phenotype (Figure S3). To monitor mRNA
knockdown more widely, qPCR was performed for a number of
target genes, encompassing cell lines with both loss of fitness
Figure 1. The trypanosome kinome. A stylised representation of the ePK complement in T. brucei. Protein kinases are grouped together into
families defined by amino acid sequence similarities [51]. The node arrangements and lengths of the branches do not have any phylogenetic
significance, and are for illustrative purposes only. Red nodes denote PKs, which, when depleted in this study, resulted in a loss of fitness phenotype.
doi:10.1371/journal.ppat.1003886.g001
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phenotype and no phenotype upon RNAi induction. Transcripts
were substantially reduced (typically by 40–60%) for 11 of the 12
other genes studied by qPCR (Figure S3). For MKK5, qPCR
indicated there to be inefficient knockdown of mRNA. While
MKK5 is known to be redundant in BSF parasites [33], this does
raise the possibility that other false negatives arising from
inefficient mRNA knockdown may be present within the screen
dataset.
Figure 2. Protein kinases involved in the cell cycle. In vitro growth and cell cycle analysis for ATR (A) and CLK1 (B). A: Upper left: growth curves
showing cumulative cell counts over time following tetracycline (Tet) induction (+) or not (2) of RNAi cell line in culture. Cell densities were
maintained between 105 and 106 cells ml21. Upper right: DAPI staining. Cells were stained with DAPI and the number of nuclei (N) and kinetoplasts
(K) per cell was quantified (n.200) at the time-points indicated. Lower panel: flow cytometry profiles for 50,000 propidium iodide labelled cells at
24 hr or 48 hr post-induction. The DNA content of each peak is indicated. B: legend as for A, but including in upper right panel an analysis of the
cytokinesis stage of 2N2K cells following tetracycline (Tet) induction (+) or not (2) of CLK1 RNAi cell line in culture. Lower left panels: flow cytometry
profiles at 6 and 12 hours post-induction. Lower right: proliferation of CLK1 RNAi line in mice. 16105 trypanosomes were inoculated in 4 mice and
RNAi was induced with doxycycline (Dox, as indicated) in 2 mice 48 hr later. Uninduced mice were culled as indicated ( ) when their parasitaemias
rose above 108 cells ml21.
doi:10.1371/journal.ppat.1003886.g002
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Correlation with the genome wide RITseq screen of Alsford
[24] was also good, with 70% of the individually targeted genes
giving the same 3 day growth phenotype. A severe growth
phenotype (defect apparent at 3 days post-RNAi induction) was
detected for 20 PKs by Alsford, but not in this study (Table S1). In
contrast, this study identified 25 PKs whose depletion resulted in a
growth defect that were not identified by Alsford (Table S1). The
variance between the two studies is likely to have arisen through
Table 1. Summary of the characteristics of RNAi cell lines displaying loss of fitness phenotypes as determined by Alamar Blue
assay and growth curves.
Family Name GeneID Growth defect Cell cycle defect Reference
AGC Tb927.3.2440 Death C
AGC PDK1 Tb927.9.4910 Slow No
AGC/NDR PK50 Tb927.10.4940 Arrest C [16]
AGC/NDR PK53 Tb927.7.5770 Slow K/C [16]
AGC/PKA* PKAC1/PKAC2 Tb927.9.11100/Tb927.9.11030 Slow C [28]
CAMK Tb927.7.6220 Arrest C
CAMK Tb927.7.2750 Slow No
CK/CK1* CK1.1/CK1.2 Tb927.5.790/Tb927.5.800 Death K/C [30]
CMGC Tb927.11.5340 Slow M
CMGC/CDK CRK1 Tb927.10.1070 Slow G1/S [11]
CMGC/CDK CRK2 Tb927.7.7360 Slow No
CMGC/CDK CRK3 Tb927.10.4990 Death M [11]
CMGC/CDK CRK6 Tb927.11.1180 Slow No
CMGC/CDK CRK9 Tb927.2.4510 Death K
CMGC/CDK CRK12 Tb927.11.12310 Death No [23,27]
CMGC/CLK CLK1 Tb927.11.12410 Death M/C [22]
CMGC/GSK GSK3-short Tb927.10.13780 Arrest M/C [29]
CMGC/MAPK Tb927.10.5140 Death C
CMGC/MAPK KFR1 Tb927.10.7780 Slow No
CMGC/RCK Tb927.3.690 Death C
CMGC/SRPK Tb927.6.4970 Arrest No
Orphan PK6 Tb927.9.10920 Arrest No
Other/AUR AUK1 Tb927.11.8220 Death M [12,13]
Other/AUR AUK3 Tb927.9.1670 Slow M/C
Other/CAMKK Tb927.10.15300 Slow No
Other/CK2 CK2A1 Tb927.9.14430 Arrest K
Other/NEK NEK12.2/RDK2 Tb927.4.5310 Death K/C
Other/TLK* TLK1/TLK2 Tb927.4.5180/Tb927.8.7220 Death M/C [14]
Other/ULK Tb927.11.4470 Arrest K/C
Other/WEE WEE1 Tb927.4.3420 Slow No
STE Tb927.10.2040 Death No
STE/STE11 Tb927.11.2040 Arrest No
STE/STE11 RDK1 Tb927.11.14070 Slow No
STE/STE20 SLK1 Tb927.8.5730 Arrest No
STE/STE20 SLK2 Tb927.9.12880 Arrest No
Pseudo Other/NAK Tb927.9.6560 Arrest No
Pseudo Orphan Tb927.7.3210 Slow U
aPK/PIKK ATR Tb927.11.14680 Arrest M
aPK/PIKK TOR1 Tb927.10.8420 Slow U [20]
aPK/PIKK TOR2 Tb927.4.420 Death No [20]
aPK/PIKK TOR4 Tb927.1.1930 Slow G1/S [6]
aPK/RIO RIO1 Tb927.3.5400 Arrest No
aPK/RIO RIO2 Tb927.6.2840 Arrest No
C, cytokinesis; M, mitosis; K, kinetoplast duplication/segregation; U, unclassified. Asterisks indicate RNAi cell lines targeting $1 PK.
doi:10.1371/journal.ppat.1003886.t001
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the use of different strains of T. brucei, different RNAi constructs
and different methods for assessing cell growth, highlighting the
importance of using complementary approaches in such studies.
Screening protein kinases important for BSF proliferation
for cell cycle defects
The 42 RNAi cell lines displaying a growth defect in culture
were analysed using DAPI staining to identify PKs with a potential
role in cell cycle control (see Tables 1, S2, Figures 2, S2 B–G). The
nucleus and kinetoplast undergo discrete replication cycles in T.
brucei, with the kinetoplast commencing replication slightly ahead
of the nucleus. A cell in G1 phase has 1 nucleus and 1 kinetoplast
(1N1K cell), while a cell in G2/M phase will have 1 nucleus and 2
kinetoplasts (1N2K) and a cell that has undergone mitosis but has
not yet undergone cytokinesis will have 2 nuclei and 2 kinetoplasts
(2N2K). Any other NK configuration is abnormal. Growth curves
were used to determine the optimal time points for performing
DAPI staining (before, during and after the appearance of the
growth defect) for each cell line and flow cytometry was used to
confirm the DAPI cell cycle analysis for specific cell lines (Figures 2
and S2H). Eighteen cell lines, including CRK2, CRK6 and
CRK12 [11,27], did not exhibit any obvious cell cycle defects, or
only displayed cell cycle changes after the emergence of the growth
defect, suggesting that these kinases are unlikely to play a direct or
specific role in cell cycle regulation (Tables 1, S2, Figure S2
B,D,F).
Twenty-four cell lines displayed cell cycle defects following
RNAi induction (Tables 1, S2, Figures 2, S2 C, E, G). The
phenotypes obtained with six of these cell lines were consistent
with published literature: PK50 [16], PKAC1/PKAC2 [28],
CRK1 and CRK3 [11], AUK1 [12,13] and TOR4 [6], while two,
including TOR1 whose depletion has previously been reported to
arrest cells in G1 [20], showed phenotypes that could not be
classified due to the lack of a pattern in aberrant cell types. It is
possible that TOR1 was knocked down less efficiently in our cell
line, since we only observed slow growth rather than growth arrest
following RNAi induction. Similarly, with PK53, a different
phenotype was observed than reported previously [16]; induced
RNAi cells displayed slower growth rather than cell death, and
rather than depletion of PK53 blocking cells during cytokinesis
furrowing, increased numbers of 2N1K cells were observed,
suggesting that PK53 depletion affected kinetoplast and/or basal
body replication and/or segregation. Such a discrepancy might be
explained by differing levels of PK53 knockdown in the two
studies. PKs targeted by the remaining 15 cell lines were identified
as novel cell cycle regulators (Tables 1, S2, Figures 2, S2). Several
of these kinases appear to play roles in kinetoplast division.
Depletion of CRK9 or CK2A1 resulted in a reduction in 1N2K
and 2N2K cells, accompanied by an increase in abnormal cell
types, of which the most abundant were 2N1K cells (13% and
19% total cells for CRK9 and CK2A1 RNAi, respectively, at
48 hours post-induction), suggesting defects in kinetoplast replica-
tion or segregation. Previously, CRK9 was reported to affect
mitosis and cytokinesis in PCF T. brucei, but no phenotype was
detected upon depletion of CRK9 in the BSF [34].
Depletion of CK1.1/CK1.2 resulted in dramatic increases in
2N2K and abnormal cells from 20 hours post-induction. The most
abundant abnormal cells were 2N1K cells, which comprised 16%
of total cells at 24 hours post-induction. The remainder of the
abnormal cells had a variety of N/K configurations (including
.2N.2K cells), but no zoids were detected. Taken together, these
data suggest down-regulation of CK1.2 (CK1.1 is redundant in
BSF T. brucei) may affect kinetoplast division and cytokinesis,
adding to existing data showing that this kinase is essential [30].
Similarly, depletion of NEK12.2 resulted in increased 2N2K and
abnormal cells (of which the majority were 2N1K cells with no
zoids detected) from 35 hours post-induction, suggesting that this
kinase also (in addition to a role in BSF to PCF differentiation
described below) regulates kinetoplast division and cytokinesis.
Down-regulation of Tb927.11.4470 led to increased 2N2K and
abnormal cell types (2N1K as well as cells with multiple nuclei
and/or kinetoplasts (.2N.2K cells)) at 48 hrs post-induction,
potentially indicating a role for this kinase in kinetoplast
replication/segregation and/or cytokinesis. Two kinases, the
CMGC kinase, Tb927.11.5340, and ATR (Figure 2A) appear to
be mitotic regulators, since their depletion resulted in increased
1N2K and 1N.2K cells (more dramatic upon ATR RNAi where
these cell types comprised 33% and 15% of the total cells,
respectively, at 48 hours post-induction). Flow cytometry indicated
that DNA replication had occurred in these cells (Figure S2H),
suggesting that progression through mitosis was inhibited, invoking
the mitosis to cytokinesis checkpoint [35] allowing kinetoplast re-
replication in the absence of cell division. Four kinases, the AGC
kinase Tb927.3.2440, the CAMK, Tb927.7.6220, MPK2 and the
CMGC/RCK kinase Tb927.3.690 were identified as being
essential for cytokinesis, since their depletion resulted in the
accumulation of 2N2K and .2N.2K aberrant cell types.
Depletion of Tb927.3.2440 and Tb927.3.690 resulted in the most
dramatic phenotypes, with almost all cells being abnormal by
48 hours post-induction.
Additionally, four PKs (GSK3-short, AUK3, TLK2 and CLK1)
may play roles in either or both mitosis and cytokinesis. GSK3-
short RNAi resulted in slight increases in 1N2K and 2N2K cells
and the appearance of small numbers of ‘other’ abnormal cell
types (including 2N1K and 0N1K cells), and only minor changes
to the flow cytometry profile (Figure S2H), suggesting DNA
replication proceeded normally followed by a possible delay in
mitosis and/or defects in cytokinesis. Previous studies of GSK3-
short have shown it to be essential for viability in BSF T. brucei and
validated it as a potential drug target, but have not examined its
cell cycle phenotype [29]. RNAi of AUK3 resulted in large
numbers of ‘other’ cell types appearing from 18 hours post-
induction. The most common types of abnormal cells were 2N1K
and 0N1K cells, together comprising ,70% and ,60% of the
abnormal cell population at 18 and 24 hours, respectively. Also
prevalent were cells with multiple nuclei and/or kinetoplasts
(.2N.2K; 17% and 31% at 18 and 24 hours, respectively). Thus,
it is possible that AUK3 is involved in mitosis and/or cytokinesis
since a delay in mitosis or defects in furrow ingression during
cytokinesis could result in the generation of these cell types [35].
Depletion of TLK1/TLK2 resulted in a large increase in 1N2K
and 0N1K cells, reaching 43% and 13%, respectively, at 36 hours
post-induction, concomitant with a reduction in 2N2K cells. Flow
cytometry revealed an increase in the ,1C peak and a decrease in
the 2C peak, consistent with the increase in 0N1K cells and
decrease in proportion of 1N1K cells, respectively, and a shift of
the 4C DNA content peak to the right, indicating that many cells
(presumably 1N2K and ‘others’) were aneuploid and had over-
replicated their DNA (Figure S2H). Previously, TLK1 depletion in
BSF was shown to cause defective spindle formation and
chromosome segregation, resulting in an increase in 1N2K and
abnormal cells (but not zoids), but did not affect 2N2K cell
numbers [36]. While TLK2 depletion did not result in any
observable phenotype in PCF T. brucei [14], it is possible that it
does play a role in BSF, accounting for the differences in
phenotype between the TLK1/TLK2 double knockdown and
TLK1 single knockdown cell lines. Thus, in BSF T. brucei, it is
possible that knockdown of TLK1 and TLK2 inhibits mitosis but
Trypanosoma brucei Protein Kinases
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does not trigger the mitosis to cytokinesis checkpoint, resulting in
inappropriate cytokinesis in 1N2K cells leading to the formation of
zoids (0N1K cells). This would imply that TLK2 is involved in this
checkpoint. Given that many cells were aneuploid, it may be that
cells reinitiated DNA synthesis (but did not complete it) prior to
cytokinesis occurring in 1N2K cells.
Depletion of CLK1 resulted in a dramatic increase in 1N2K,
2N2K and abnormal cell types from 6–9 hrs post-induction
(Figure 2B). At 9 hours post-induction, the majority of the
abnormal cell types had configurations of 2N3K or 2N4K, but
at later timepoints, the N/K configurations of many cells became
difficult to accurately determine since discrete nuclei and
kinetoplasts could no longer be seen. Flow cytometry revealed a
decrease in the 2C peak and an increase in the 4C peak (Figures 2
and S2), consistent with an accumulation of cells that had
replicated their DNA. These data suggest mitosis and cytokinesis,
but not DNA replication, were deregulated in these cells. To
investigate the possible cytokinesis defect further, the cytokinesis
stage of .200 2N2K cells was determined up to 12 hours post-
induction, showing that the majority of the accumulated 2N2K
cells had no furrow and were therefore yet to commence
cytokinesis. Thus, CLK1 appears to be required for mitosis and
entry into cytokinesis and is also essential for survival of
trypanosomes in a mouse model, thereby validating CLK1 as a
potential drug target [22].
In summary, cell cycle screening of our kinome RNAi library
has allowed putative cell cycle functions to be assigned to 15 PKs
for the first time, although further, more detailed analyses will be
required to confirm these functions. However, the fact that we
were also able to reproduce a number of RNAi phenotypes
obtained for PKs studied previously provides a level of confidence
in the screen findings. The simple cell cycle screen applied here
was also sensitive enough to be able to pick up defects across the
whole cell cycle from G1/S to kinetoplast division to mitosis and
cytokinesis. Since additional simple screens e.g. using immunoflu-
orescence to investigate replication of organelles and/or structural
components of the trypanosome cell or flow cytometry to
investigate DNA replication could be applied to identify the PKs
responsible, this library adds to the tool-kit for the study of the T.
brucei cell cycle.
Identification of a STE11-like ePK that represses
bloodstream to procyclic form differentiation
Differentiation of T. brucei BSF parasites to PCF parasites
involves major changes in gene and protein expression, metabo-
lism and morphology (reviewed in [3]). A protein phosphatase
cascade has been shown to regulate the differentiation of stumpy
BSF parasites to PCF parasites [7,8], but to date, no protein
kinases regulating this process have been identified. Here, PKs
involved in the negative regulation of differentiation were sought
by microscopic evaluation of cells 72 hr after tetracycline
induction, looking for morphological changes consistent with
differentiation from the BSF to the PCF [37]. Following induction,
the presence of cells with PCF-like morphology was detected for
the STE11-like PK, Tb927.11.14070, RNAi cell line which had
not shown a noticeable loss of fitness in the Alamar Blue screen.
Immunofluorescence analysis showed that RNAi of Tb927.11.
14070led to expression of the PCF–specific surface protein, EP
procyclin [37], and that the kinetoplast repositioned to midway
between the posterior of the cell and the nucleus, in a manner
characteristic of PCF cells (Figure 3A). Following RNAi induction
and growth at 37uC, the proportion of EP procyclin positive cells
reached 20% by 72 hr, as assessed by flow cytometry (Figure 3B),
which is consistent with the percentage of differentiation
competent stumpy-like parasites (stumpy*) in the monomorphic
2T1 cell line [25]. These data indicate that this PK, named
Repressor of Differentiation Kinase 1 (RDK1), is a repressor of
BSF to PCF differentiation; depletion of RDK1 allows differen-
tiation-competent cells to proceed to the procyclic form even at
37uC, the temperature of the mammalian bloodstream which is
higher than that found during natural transmission in the tsetse
(nominally 27uC). To investigate further the effect of RDK1
depletion, growth curves were performed for RDK1 RNAi
lines cultured in vitro at 37uC. Slow growth was detected from
48 hr post-induction for RDK1 RNAi lines (Figure 3C). Knock-
down of RDK1 was confirmed at the mRNA level by qPCR
(Figure S3) and at the protein level by expressing a C-terminal
12-Myc tagged version of RDK1 (RDK1::12myc) from the
endogenous locus and Western blotting (Figure 3C). RDK1 is
predicted (using the TMHMM algorithm) to contain three
transmembrane domains in the N-terminal domain, with the
PK domain at the C-terminus (Figure 3D) suggesting that
RDK1 is a membrane protein. The third predicted transmem-
brane domain corresponded to a region predicted to be disordered
and may be a false positive; therefore, the number and topology
of the TM domains remains unclear. Cell fractionation analysis
showed that RDK1::12myc was associated with the membrane
fraction (Figure 3E) as RDK1::12Myc was found in the
supernatant fraction of a detergent based lysis, which contains
membrane and cytoplasmic components, and in the pellet fraction
of a hypotonic lysis which contains membrane and cytoskeletal
proteins. This fractionation pattern was the same as that observed
for MCA4, a protein previously identified as cell membrane
associated [38]. Immunofluorescence microscopy was performed
with an anti-Myc antibody to detect RDK1::12Myc in an
RDK1 RNAi background (see above). In uninduced cells,
RDK1::12Myc staining outlined the cell body and was also
present on the flagellum, although often the flagellum staining was
much weaker than the cell body staining (Figure 3F). Upon
induction of RDK1 RNAi, the RDK1::12Myc signal outlining the
cell body disappeared by 22 hours post-induction, and the
flagellum staining was much reduced. This might suggest that
RDK1 is turned over more slowly in the flagellum than in the rest
of the cell. These data support a cell membrane location for
RDK1, which correlates with the identification of RDK1 in the
flagellum surface proteome and the annotation of RDK1 as a cell
surface receptor kinase [39].
In order to provide further evidence that the cells were
differentiating to true PCF parasites, rather than simply remod-
elling their morphology and cell surface, the transcriptome of the
RDK1 RNAi induced cells was examined by RNA-Seq analysis.
At 48 hr post-induction, mRNA was extracted from induced and
uninduced RDK1 RNAi cell lines and sequenced. Analysis of
differentially regulated transcripts identified a total of 479 genes
whose expression was significantly different in the induced and
uninduced samples, of which 275 were identified in both biological
replicates. 145 of these were down-regulated (Table S3). These
were compared with genes previously identified as being
differentially expressed in BSF or PCF trypanosomes by micro-
array or RNA-Seq [40,41]; 236 of the 275 differentially expressed
genes detected in RDK1 RNAi induced cells were also identified
as differentially expressed genes in these studies, including
procyclic form-specific proteins, EP- and GPEET- procyclin,
and trans-sialidase and BSF specific proteins ESAG and ISG64.
Hence, despite only 5% of cells having morphological and cell
surface signatures of procyclic form parasites at 48 hours post-
induction, the transcriptome data support a BSF to PCF
differentiation process occurring after ablation of RDK1.
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The T. brucei 2T1 monomorphic cell line becomes more
responsive to signals of differentiation when treated with cell
permeable, hydrolysable cAMP analogues [42], as the parasites
undergo cell cycle arrest and express stumpy-specific genes such as
PAD1 [1,3,42]. To test if RDK1 acts in a signalling pathway that
is parallel to, or downstream of, SIF, the RDK1 RNAi line was
treated with 250 mM 8-(4-chlorophenylthio)-cAMP (8-pCPT-
cAMP). Incubation with 8-pCPT-cAMP led to a 2-fold increase
in expression of the stumpy gene PAD1, which encodes a
carboxylate surface transporter (Figure 4A), suggesting an increase
in differentiation-receptive stumpy* parasites. When 8-pCPT-
cAMP treatment was applied to cells depleted of RDK1, the
percentage of EP procyclin positive cells increased ,2-fold from
20% to 38% after 72 hr (Figure 4B), indicating an additive
response to the depletion of RDK1 and the induction of stumpy*
formation. The effect was even more pronounced following 24 hr
cold shock at 27uC, when 60% of cells were EP procyclin positive
in the induced cell line (Figure 4C). Similarly, when the PTP1
phosphatase inhibitor BZ3 [7] was incubated with the RDK1
RNAi induced cell line, the proportion of EP procyclin positive
cells increased from 20% to 60% after 72 hr, indicating an
additive response to the depletion of RDK1 and the inhibition of
PTP1 (Figure 4D). These data suggest that the protein kinase,
RDK1, and the tyrosine phosphatase, PTP1, are working together
Figure 3. RDK1 is a repressor of BSF to PCF differentiation. A: RDK1 RNAi was induced for 72 hours before cells were analysed by
(immuno)fluorescence microscopy with DAPI (to stain nuclei and kinetoplasts) and FITC-conjugated anti-EP procyclin. Left panel: DIC images; right
panel: merged fluorescence channels - DAPI (blue), EP-procyclin (green). Scale bar: 10 mm. B: quantification of EP procyclin-expressing cells by flow
cytometry over time following induction of RDK1 RNAi. C: Growth curves showing cumulative cell counts over time following tetracycline (Tet)
induction (+) or not (2) of RDK1 RNAi in culture. Cell densities were maintained between 105 and 106 cells ml21. Error bars indicate the standard
deviations around the means of three technical replicates. Inset: Analysis of RDK1 protein knockdown following RNAi induction. RDK1 RNAi cell line
clone 1 expressing RDK1::12Myc from the endogenous locus was analysed by Western blotting with an anti-Myc antibody 24 hr after RNAi induction.
Anti-EF1a antibody was used as a loading control. D: predicted domain structure of RDK1. TM: transmembrane domain. E: cell fractionation. Cells
expressing RDK1::12myc were fractionated and analysed by Western blotting with anti-Myc antibody to detect RDK1::12myc and anti-OPB, anti-b-
tubulin and anti-MCA4 antibodies as cytoplasmic, cytoskeletal and membrane protein controls, respectively. T: total cell lysate; DS: detergent-soluble;
DP: detergent-pellet; HS: hypotonic soluble; HP: hypotonic pellet. F: immunofluorescence of RDK1::12Myc expressed in an RDK1 RNAi background.
Cells were induced (+) or not (2) with tetracycline (Tet) for 22 hr and fixed, permeabilised and labelled with DAPI (blue) and an anti-Myc antibody
(green). Left: DIC image; right: DAPI/Myc merge. Scale bar: 5 mm.
doi:10.1371/journal.ppat.1003886.g003
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as repressors of differentiation in discrete signalling pathways that
respond to the SIF differentiation signal. RDK1 has some
sequence identity with STE11-like MAP kinase kinase kinases,
which operate with STE5 scaffold proteins to phosphorylate STE7
PKs within a MAP kinase signalling cascade. No STE5 proteins
have been identified in trypanosomes, raising the possibility that
the 2 or 3 trans-membrane domains of RDK1 act to anchor the
protein in the membrane and initiate a MAP kinase signalling
cascade that represses differentiation of BSF to PCF; such a
pathway would be likely to operate in association with the PTP/
PIP39 phosphatase cascade [3,7,8].
Identification of a NEK family ePK that represses
bloodstream to procyclic form differentiation
The NEK family of PKs is highly expanded in number in T.
brucei in comparison with humans, and the family was predicted to
contain protein kinases with parasite-specific functions. Simulta-
neous depletion of two closely related NEK kinases, NEK12.1 and
NEK12.2 (Tb927.8.7110 and Tb924.4.5310), resulted in a severe
growth phenotype both in culture and in a mouse model (Figure
S4), making one or other or both of these NEK kinases potential
drug targets. NEK12.1 is unusual as it is one of only two T. brucei
ePKs to possess a small gatekeeper residue (A117) in its ATP
binding pocket; NEK12.2 possesses a bulkier methionine gate-
keeper residue (M117). This suggests that the active site pocket of
NEK12.1 is larger than that of NEK12.2 and other active PKs in
T. brucei, and is likely to be able to accommodate bulky ATP
inhibitors that do not fit within the ATP binding pocket of PKs
with bulkier gatekeeper residues [43]. NEK12.2 has an N-terminal
protein kinase domain and a pleckstrin homology (PH)-like
domain at the C-terminus (Figure 5A). The NEK12.1 and
NEK12.2 paralogues share 87% DNA sequence identity, and their
high sequence similarity and location on chromosomes 8 and 4,
respectively, mean that they may have resulted from a chromo-
some translocation [44].
To investigate the role of each kinase, individual NEK12.1 and
NEK12.2 RNAi cell lines were generated by creating RNAi target
sequences through the joining of short DNA sequences ($20 nt)
taken from small, divergent regions spread across each gene.
Figure 4. Analysis of differentiation during RDK1 RNAi. A: qRT-PCR analysis of PAD1 mRNA expression after 24 hr treatment of uninduced
RDK1 RNAi cells with 250 mM 8-pCPT-cAMP. B–D: quantification of EP procyclin-expressing cells by flow cytometry following induction of RDK1 RNAi.
RNAi of RDK1 was induced for 24, 48 and 72 hr by addition of tetracycline (Tet) and the percentage of EP-procyclin positive cells detected by flow
cytometry after treatment with 250 mM 8-pCPT-cAMP (B), cold shock treatment of cells at 27uC (C) or incubation with 150 mM BZ3 (D) for the final
24 hr of each RNAi induction.
doi:10.1371/journal.ppat.1003886.g004
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Induction of NEK12.2 RNAi resulted in cell death after 72 hr
(Figure 5B), whilst NEK12.1 grew at the same rate as the
uninduced cell line (not shown). qPCR confirmed mRNA
knockdown for NEK12.1 and NEK12.2 in their respective RNAi
lines (Figure 5B, Figure S3, Figure S4). NEK12.1 mRNA was also
observed to decrease under NEK12.2 RNAi induction; however,
as the RNAi sequences targeted equivalent regions of each gene
and NEK12.2 mRNA was not observed to decrease after
NEK12.1 RNAi induction, cross targeting was not thought to be
occurring. Instead, it was suspected (see below) that NEK12.2
RNAi triggers a spontaneous PCF differentiation phenotype
similar to the one observed in RDK1 RNAi cell lines, and
Figure 5. RDK2 is a repressor of BSF to PCF differentiation. A: Predicted domain structure of RDK2. PH: pleckstrin homology domain. B:
Growth curves showing cumulative cell counts over time following tetracycline (Tet) induction (+) or not (2) of RDK2 RNAi in culture. Cell densities
were maintained between 105 and 106 cells ml21. Error bars indicate the standard deviations around the means of three technical replicates. Inset:
qRT-PCR analysis of RDK1 mRNA knockdown following RNAi induction. C: quantification of EP procyclin-expressing cells by flow cytometry following
induction of RDK2 RNAi. RNAi of RDK2 was induced for 24 and 48 hr by addition of tet and the percentage of EP-procyclin positive cells detected by
flow cytometry after treatment with 250 mM 8-pCPT-cAMP (D), cold shock treatment of cells at 27uC (E) or incubation with 150 mM BZ3 (F) for the
final 24 hr of each RNAi induction.
doi:10.1371/journal.ppat.1003886.g005
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NEK12.1 mRNA has been shown previously to be down-
regulated in differentiating parasites and PCF parasites compared
to BSF [41,45]. These data suggest that NEK12.2 is an essential
PK and may play a role in parasite differentiation, which was
investigated further.
Following NEK12.2 depletion, the morphology of the cells
appeared PCF-like, so immunostaining for EP procyclin was
conducted. When analysed by flow cytometry, 40–60% of cells
were EP procyclin positive after 48 hr of NEK12.2 RNAi
induction (Figure 5C–F), demonstrating a more rapid and more
severe phenotype than observed in induced RDK1 RNAi cells.
Immunofluorescence microscopy showed that the EP procyclin
positive cells had repositioned their kinetoplast to midway between
the posterior of the cell and the nucleus (not shown). These data
indicate that NEK12.2 (renamed RDK2) is also a repressor of BSF
to PCF differentiation. In contrast to RDK1 RNAi, incubation of
the induced RDK2 RNAi line with 8-pCPT-cAMP or subjecting it
to cold shock (27uC) did not potentiate the differentiation
phenotype (proportion of EP procyclin positive cells) (Figure 5D,
5E), indicating that RDK2 depletion is sufficient to induce
differentiation of the entire sub-population of bloodstream form
cells that is sensitive to these differentiation triggers. Additionally,
treatment of induced RDK2 RNAi cells with BZ3 did not increase
the proportion of EP procyclin positive cells (Figure 5F); rather,
BZ3 treatment actually resulted in a decrease in such cells, hinting
at a possible negative feedback mechanism. While the cell death
phenotype associated with RDK2 RNAi (most likely due to the
observed cell cycle defects in kinetoplast division and cytokinesis,
see above) complicates the interpretation of these data and
prevented analysis of the differentiation phenotype over a longer
time period, the efficiency with which RDK2 depletion induces
differentiation in the absence of other triggers suggests RDK2
plays a vitally important role in controlling BSF to PCF
differentiation.
Concluding remarks
This study demonstrates that it is feasible to perform large scale
functional analysis of gene families, since the recombineering-
based system used to generate the library of RNAi plasmids has
proven to be efficient, robust and rapid. This should facilitate
RNAi studies on other large gene families, or even the complete
genome. Additionally, the kinome library of RNAi cell lines itself is
an important resource, since it permits systematic and global
analysis of PK signalling in T. brucei. The ability to use the 2T1
derived cell lines with endogenous tagging constructs or other
expression cassettes further allows the generation of reporter cell
lines to interrogate the role of each PK in controlling any cellular
process of interest.
This study confirms the importance of protein phosphorylation
to the parasite [46]; while the absence of a proliferation phenotype
upon RNAi induction does not provide sufficient evidence that a
gene is non-essential, this study has identified at least 42
(considering the double knockdown cell lines) out of 190 PKs
(22.1%), to be required for normal BSF proliferation. 13 of these
PKs are worthy of prioritisation as drug targets, as RNAi induced
cell lines die very rapidly upon RNAi induction. These include the
CMGC PKs CRK3, CRK9, CRK12, CLK1, Tb927.10.5140 and
Tb927.3.690, the AGC PK Tb927.3.2440, CK1.1, AUK1,
RDK2, TLK, TOR2 and the STE PK Tb927.10.2040. Chemical
proteomic profiling has shown that T. brucei PKs are sensitive to
inhibitors with nM potency [18] and hypothemycin, a fungal
natural product with anti-trypanosomal activity, inhibits both
GSK3short and CLK1 [22], providing support for the concept
that trypanosome-specific inhibitors can be developed.
Cell division in trypanosomes is tightly regulated and genetic
perturbation leads readily to the formation of aberrant cells [10].
22 PKs gave a defined cell cycle defect upon RNAi induction, with
the majority blocked in mitosis or cytokinesis and surprisingly few
in G1/S (Figure 6). A more defined cell cycle analysis that focuses
on G1/S-specific markers could be designed to identify PKs
involved in regulating G1 transition and entry into S phase, early
cell cycle events such as basal body duplication or Golgi
replication, DNA replication or positive regulators of differentia-
tion that promote formation of cell cycle arrested stumpy form
parasites. However, major challenges for the future will be to link
individual PKs in signalling cascades, and, given that a high
proportion of trypanosome PKs are differentially phosphorylated
between the bloodstream and procyclic form ([19,46] and Table
S1), to determine life cycle stage-specific signalling pathways as
well as identify those that are divergent in other eukaryotes.
The study also identified the first two PKs involved in repressing
BSF to PCF differentiation. Although depletion of either RDK1 or
RDK2 promotes BSF to PCF differentiation, key differences were
noticed. Irrespective of the approaches used to induce differenti-
ation of logarithmically growing T. brucei 2T1, a maximum of 60%
of cells within the population were found to be receptive to signals
of differentiation under the time frames studied here. However,
only 20% of cells undergo differentiation upon RDK1 RNAi and
these appear to be separate from the cells that are induced to
differentiate when PTP1 is inhibited by BZ3. In contrast, 40–60%
of cells undergo differentiation upon RDK2 RNAi suggesting that
RDK2 might act to prevent differentiation of all cells within the
population that are receptive to the various differentiation signals,
and as such might act upstream of both RDK1 and PTP1. The
identification of two protein kinases (this study) and two
phosphatases [7,8], which act as repressors of differentiation
(Figure 6), highlight the importance of cell signalling by reversible
phosphorylation in preventing inadvertent expression of procyclic-
specific genes in the mammalian bloodstream. The phenotype
induced by RDK1 and RDK2 (expression of procyclin) would be
suitable for a target-based, phenotype-directed high content cell
screen for regulators of differentiation using protein kinase
focussed chemical libraries. Specific anti-RDK inhibitors would
be useful chemical tools for investigating trypanosome differenti-
ation and could also be potential lead compounds for drug
development.
Materials and Methods
Ethics statement
All animal procedures were undertaken in adherence to
experimental guidelines and procedures approved by The Home
Office of the UK government. All work was covered by Home
Office Project Licence PPL60/4442 entitled ‘‘Molecular Genetics
of Trypanosomes and Leishmania’’. All animal protocols received
approval from the University of Glasgow Ethics Committee.
Generation of kinome RNAi library
The pRPaISL plasmid [25] was redesigned in silico to contain
two, inverted Gateway donor sites (containing attP sites and a ccdB
counter selectable marker) separated by 150 bp of the lacZ gene.
This modification was synthesised (Blue Heron Biotech) and
cloned between the BamHI and XbaI sites of pRPAISL. The
resultant plasmid, termed pGL2084, was propagated in ccdB
Survivor cells (Invitrogen) at 25uC. RNAi target sequences were
determined for the CDS of each PK gene using the TrypanoFAN:
RNAit programme [47]. RNAi targets were amplified from T. b.
brucei TREU 927 genomic DNA using Phusion high fidelity
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polymerase (NEB, Massachusetts) with appropriate oligonucleo-
tide pairs (Table S3) incorporating attB1 and attB2 sites before
being cloned into pGL2084 in a BP Recombinase reaction
(Invitrogen) as per the manufacturer’s instructions. 12 PKs were
cloned into unmodified pRPaISL (indicated in Table S1). The
resultant plasmids (pTL) were propagated using DH5a Max
Efficiency cells, and purified and digested with AscI (NEB) prior to
transfection.
T. b. brucei 2T1 BSF cells and derivatives were maintained in
HMI-11 (HMI-9 (GIBCO), 10% v/v foetal calf serum (FCS;
GIBCO 10270), Pen/Strep (SIGMA) (penicillin 20 Uml21,
streptomycin 20 mgml21)), at 37uC, 5% CO2 in vented flasks
[48]. Appropriate selective drugs were added at the following
concentrations: 2 mg ml21 puromycin, 2.5 mg ml21 phleomycin
(InvivoGen), 5 mg ml21 hygromycin B (Calbiochem) and
10 mg ml21 blasticidin (InvivoGen). BSF parasites were transfect-
ed as previously described [27], with independent clones obtained
by limiting dilution. Clones were screened for puromycin
sensitivity [25]; puromycin sensitive clones were prioritised for
further analyses.
In order to specifically target each individual NEK12 mRNA,
the NEK12.1 and NEK12.2 genes were aligned and short regions
(over 20 nt) were identified where enough divergence existed to
enable gene specific silencing by RNAi. For each gene, five small
fragments (targeting the equivalent regions of each gene) were
identified and joined in silico, then synthesised into attB flanked
inserts (Genscript) ready for Gateway cloning into pGL2084.
CLK1/2 individual RNAi constructs were generated by targeting
the diverged 59 region of the CDS and 59 UTR.
Assessment of growth and cell cycle status following
RNAi induction
Cell cultures were adjusted to 26104 cells ml21 and divided into
two pools. RNAi was induced in one pool by the addition of
tetracycline to a final concentration of 1 mg ml21 in 70% ethanol,
while the other was treated with an equivalent volume of 70%
ethanol. 200 ml of each culture was then plated in triplicate into
wells of a 96 well plate and incubated for 48 hr at 37uC in the
presence of 5% CO2. Twenty microlitres of Alamar Blue
(0.49 mM resazurin in phosphate-buffered saline (PBS)) was
Figure 6. Schematic representation of the BSF trypanosome cell cycle and differentiation from BSF to PCF. Protein kinases implicated
in cell cycle control and differentiation are indicated (red font: cell cycle function identified in this study; black font: cell cycle function previously
identified).
doi:10.1371/journal.ppat.1003886.g006
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added to each well and the plates incubated for a further 24 hr.
The plate was then read at lexcitation 485 nm and lemission 620 nm
in an Envision Plate Reader (Perkin Elmer). The average ratio of
the values for induced wells to uninduced wells was then
calculated. A value of 1 indicated that RNAi induction did not
affect cell proliferation, while a value ,1 indicated RNAi
induction reduced cell proliferation to some extent. A cut-off
value of ,0.9 was used in this study to determine which genes
were analysed further.
To confirm the RNAi growth defects detected in the Alamar
Blue assay for cell lines with values ,0.9, one clone of each cell
line was induced with 1 mg ml21 tetracycline. Cell densities were
determined every 24 hr and cumulative growth curves plotted
taking into account the dilution factors necessary to maintain
cultures below a density of 16106 cells ml21. For analysis of
growth for RDK1 and RDK2 RNAi, 30 ml of HMI-11 was
seeded with105 cells ml21 and divided into 5 ml aliquots in a 6
well plate. Three wells were induced with 1 mg ml21 tetracycline,
and cumulative growth curves generated as described above.
Mouse infections were carried out in ICR mice; initially, a
donor mouse was infected with 56104 cultured parasites and
monitored for 72 hr. Experimental groups of 4 mice were infected
using 16105 parasites taken from the same donor mouse.
Doxycycline was added to drinking water after 48 hr to induce
gene specific RNAi in the infecting trypanosomes. Parasitaemia
was monitored daily by haemocytometer cell counting of blood
(diluted in 0.83% ammonium chloride) taken by tail venipuncture.
The cell cycle profile of RNAi cell lines over time following
induction was determined by staining cells with DAPI and
cataloguing the nucleus/kinetoplast (N/K) configuration of
.200 intact cells/timepoint [35]. For CLK1 RNAi, the cytokinesis
stage of .200 2N2K cells/timepoint was also determined as
previously described [49]. Flow cytometry was carried out as
described previously [35] but using FlowJo version 7.6.5 for
analysis (Tree Star).
RNA analysis
For qPCR analysis of RNAi lines, 26107 cells were harvested
from induced and uninduced cultures at 24 hr post-induction and
total RNA was isolated using the Qiagen RNeasy Kit (with on
column DNaseI digest) using a Qiacube Robot to minimize RNase
contamination. Samples were then further treated with RQ1
RNase-free DNaseI (Promega). To prepare cDNA, 2 mg of total
RNA were used as a template in a reverse transcriptase reaction
with random hexamers using the SuperScript Reverse Transcrip-
tase III system (Invitrogen). Following cDNA synthesis, E. coli
RNase H (Invitrogen) was added to degrade the template RNA.
qPCR reactions were set up using Applied Biosystems SYBR
Green PCR master mix as described previously [27]. A
denaturation step was added to determine that only a single
product was formed by each primer pair; primer pairs were also
tested for efficiency against the control primers to ensure accurate
comparisons could be made. The control primers used targeted
the C1 gene (Tb927.10.12970) due to its stability during
trypanosome life cycle differentiation [20]. Assays were also
performed using gene specific primers in a One STEP SYBR
PrimeScript Kit II (Takara), to increase throughput; this technique
was validated against samples analysed by the Monnerat et al.,
method [27].
For RNAseq analysis, total RNA from RDK1 RNAi cell lines (2
biological replicates, clone 1 and clone 2) was extracted from
induced (48 hr) and uninduced cultures, then prepared for
RNAseq at Glasgow Polyomics Facility (www.gla.ac.uk/
polyomics). mRNA was amplified using oligo-dT and multiplexed,
before being sequenced using an Illumina Genome Analyzer IIx.
This generated paired-end reads (4 million per sample, with an
average size of 110 bases), with an average insert size of 200 bases.
The read quality was controlled by trimming on mean quality
score .Phred 20 (equating to ,1% error rate). Non-redundant
read data were aligned to the T. b. brucei 927 reference genome
from TriTrypDB version 4.0 using Bowtie (0.12.7), and analysed
for differential gene expression using Cufflinks (1.3.0). Cufflinks
determined differentially regulated genes by calculating an
uncorrected p-value for the fold change in reads for a gene and
a q-value (a corrected p-value using a false discovery rate of 0.05).
If the p-value was less than the q-value, the gene was considered to
be significantly differentially regulated. Expression values are
reported as fragments per kilobase of exon per million reads
mapped (FPKM).
Subcellular fractionation and immunofluorescence
An allele of RDK1 was tagged endogenously with a C-terminal
12Myc epitope using the pNAT BSD612Myc vector [25]. Crude
cell fractionation was performed using detergent based or
hypotonic buffers as previously described [38]; Western blots of
the lysates were probed with the mouse monoclonal anti-Myc
antibody clone 9E10 (Millipore) to detect RDK1::12Myc, anti-
oligopeptidase B (OPB) antibody (cytoplasmic control, [50]), the
anti-b-tubulin antibody KMX (cytoskeleton control) [38]) and
anti-metacaspase 4 (MCA4) (membrane protein control, [38]).
For immunofluorescence, 16106 cells were washed in Try-
panosome Dilution Buffer (TDB; 20 mM Na2HPO4, 2 mM
NaH2PO4, 80 mM NaCl, 5 mM KCl, 1 mM MgSO4, 20 mM
glucose, pH 7.4) and fixed in 3% paraformaldehyde overnight at
4uC. After washing in PBS, cells were resuspended in 0.5 ml 0.1M
Na2HPO4/0.1M glycine pH 7.2 and incubated on ice for
15 minutes. 0.5 ml PBS/0.2% Triton X-100 was added and cells
were incubated for a further 5 minutes on ice before being washed
in 0.5 ml PBS/1% bovine serum albumin (BSA) and resuspended
in 100 ml 1/500 dilution of anti-Myc monoclonal antibody clone
4A6 (Millipore). Following a 1 hr incubation on ice, cells were
washed twice in PBS/1% BSA and then incubated in a 1/100
dilution of AlexaFluor488-conjugated anti-mouse IgG (Invitrogen)
for a further hr on ice in the dark. Cells were washed once in PBS/
BSA and once in 100 mM HEPES pH 7.5 before being incubated
in 10 mg ml21 49,6-diamidino-2-phenylindole (DAPI)/100 mM
HEPES pH 7.5 for 5 mins, washed and resuspended in 100 mM
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)
pH 7.5. Cells were examined on a DeltaVision RT epifluores-
cence imaging system with images taken with a Cool Snap HQ2
camera, deconvolved and processed using SoftWoRx software.
Monitoring BSF to PCF differentiation
The differentiation of BSF to PCF trypanosomes was routinely
monitored by flow cytometry as previously described [1]. Briefly,
36106 cells were washed in TDB, before being fixed in 2%
formaldehyde v/v, 0.05% glutaraldehyde v/v at 4uC for 1 hr.
After washing in PBS, the cells were labelled with 1/100 dilution
of FITC-conjugated anti-EP procyclin mouse monoclonal IgG1
(CLP001F, clone TBRP1/247, Cedarlane Laboratories, Ontario)
in PBS for 1 hr at room temperature. Cell fluorescence and
scattering parameters were measured on a FACS-Calibur Flow
Cytometer (Becton Dickinson), with 50 000 events being captured
per sample. Data analysis was performed using FlowJo software
(Tree Star Inc.) where gates were applied in the FSC/SSC
channels to exclude cellular debris or aggregates before a
bifurcation gate was applied to define EP procyclin positive/
negative cells. RDK1 or RDK2 RNAi was induced for 0, 24 or 48 h
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prior to the addition of 250 mM 8-pCPT-cAMP [1] or 150 mM
BZ3 (3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-
sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide), (Merck), or
prior to subjection to cold shock (27uC) for the final 24 hr of
each experiment [7].
Supporting Information
Figure S1 The stem-loop RNAi construct cloning strat-
egy. The tetracycline-inducible, stem-loop RNAi vector,
pRPaISL [25,52], was modified in a similar way to the plant
pHELLSGATE recombineering system [53]. A: Illustration of
the main features of the RNAi plasmid. Grey hygDstop and
RRNA boxes: sequences required for integration into the T. b.
brucei 2T1 cell line; ald: aldolase 39UTR; attP1 and attP2:
Gateway cloning recombination sites; ccdB: negative selectable
marker. Restriction endonuclease sites used to confirm correct
integration are shown at the top of the figure. After transfection,
the expression of the complete HYG gene is controlled by the EP
procyclin promoter (PEP) and the RNAi sequence by the
ribosomal RNA promoter (PRRNA), which has been modified by
the inclusion of a Tet operator sequence to render it inducible by
tetracycline. The position of a 150 bp LacZ stuffer fragment,
which allows E. coli to replicate the plasmid backbone without an
insert, is indicated. B: depiction of the recombination of a single
PCR product into the vector in two opposing, reverse
complemented orientations via the Gateway system BP clonase
reaction. Recombination of the attB1 and attB2 sites flanking the
PCR product with the attP1 and attP2 that flank the ccdB gene of
the vector generates attL1 and attL2 sites and results in the
excision of the ccdB marker.
(PDF)
Figure S2 Cell cycle analysis. RNAi cell lines exhibiting a
loss of fitness following induction by Alamar Blue assay were
further screened for cell cycle defects. Growth curves were
performed for 96 hours following RNAi induction with tetracy-
cline (Tet) and DAPI staining was performed to determine the
nuclei/kinetoplast (N/K) configurations of cells over time
(n.200 cells/timepoint). ‘Other’ cells are those with abnormal
N/K configurations, details of which can be viewed in Table S2.
A: Cumulative growth curves for RNAi cell lines exhibiting no
growth defect following induction; B: RNAi cell lines displaying
slow growth phenotype, but no cell cycle defect following
induction; C: RNAi cell lines displaying slow growth accompa-
nied by a cell cycle defect following induction; D: RNAi cell lines
displaying growth arrest phenotype, but no cell cycle defect
following induction; E: RNAi cell lines displaying a growth arrest
and a cell cycle defect following induction; F: RNAi cell lines
displaying a cell death phenotype, but no cell cycle defect
following induction; G: RNAi cell lines displaying cell death and
a cell cycle defect following induction. H: Flow cytometry
analysis for selected clones. The DNA content of each peak is
indicated.
(PDF)
Figure S3 Quantification of mRNA knockdown in
selected RNAi cell lines. A: qRT-PCR was performed to
assess mRNA levels (corresponding to the targeted gene) in
induced (+Tet) and uninduced (2Tet) RNAi cell lines at 24 hr
post-induction. Mean relative quantification values from 4
technical replicates with their standard deviations are presented.
Unpaired t-tests were performed for each set of data, with asterisks
indicating significant differences (p,0.05). Red bars indicate genes
for which a LOF phenotype was detected while grey bars indicate
a gene for which no LOF phenotype was observed. B: qRT-PCR
results for dual and individual NEK12 RNAi cell lines to assess
specificity of RNA knockdown.
(PDF)
Figure S4 RNAi of NEK12.1/12.2. A: Cumulative cell
counts over time following tetracycline (Tet) induction (+) or
not (2) of NEK 12.1/NEK12.2 dual RNAi cell line grown in
culture. Cell densities were maintained between 105 and 106 cells
ml21. Error bars indicate the standard deviations around the
means of three technical replicates. Inset: Analysis of NEK12.1
protein knockdown following RNAi induction. NEK12.1/
NEK12.2 RNAi cell line clone 1 expressing GFP-TY::NEK12.1
from the endogenous locus was analysed by Western blotting with
an anti-GFP antibody 24 hr after RNAi induction (+T) or not
(2T). anti-EF1a antibody was used as a loading control. B:
Proliferation of NEK12.1/NEK12.2 RNAi line in mice. 16105
trypanosomes were inoculated in 4 mice and RNAi induced with
doxycycline (Dox, as indicated) in 2 mice 24 hr later. Uninduced
mice were culled as indicated ( ) when their parasitaemias rose
above 108 cells ml21.
(PDF)
Table S1 Summary of the characteristics of the RNAi
cell lines. Alsford RITseq RNAi screen [24] loss of fitness (LOF)
phenotypes are highlighted orange (Day 3) or red (Day 6). Mackey
[21], Merritt [23] and Nishino [22] screens LOF phenotypes are
highlighted red. For the screen described in this study, Alamar
blue ratios,0.9 are highlighted in brown. Asterisks indicate RNAi
cell lines targeting $1 PK. Phosphorylation status of PKs is taken
from [46].
(XLSX)
Table S2 Details of abnormal cells accumulating fol-
lowing RNAi induction as observed by DAPI staining.
Actual numbers and percentages of each cell type observed are
shown. Separate tabs for each PK are provided and, for ease of
reference, are colour coded according to the RNAi phenotype (as
assigned in Figure S2A–G). Orange: no growth defect following
induction; purple: RNAi cell lines displaying slow growth
phenotype, but no cell cycle defect following induction; lime:
RNAi cell lines displaying slow growth accompanied by a cell cycle
defect following induction; grey: RNAi cell lines displaying growth
arrest phenotype, but no cell cycle defect following induction;
pink: RNAi cell lines displaying a growth arrest and a cell cycle
defect following induction; blue: RNAi cell lines displaying a cell
death phenotype, but no cell cycle defect following induction;
yellow: RNAi cell lines displaying cell death and a cell cycle defect
following induction.
(XLSX)
Table S3 List of differentially expressed genes identi-
fied by RNAseq following induction of RDK1 RNAi for
48 hr.
(XLSX)
Table S4 Oligonucleotides used in this study. Separate
tabs give details of (A) primer sequences used for constructing pre-
Gateway RNAi plasmids along with (B) a list of these plasmids, (C)
primer sequences for constructing Gateway RNAi plasmids, (D)
the RNAi inserts for the NEK12-specific RNAi constructs, (E)
qRT-PCR primers and (F) primers used to clone the RDK1
endogenous tagging construct.
(XLSX)
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